JENNIFER WRIGHT: Open Payments
NPI 1679179485 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 78 payments from 17 companies in 2025. Trend: 2023 $1,563 · 2024 $1,438 · 2025 $1,754
Food & beverage: $1,670Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $402 |
| Ardelyx, Inc. | 6 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $189 |
| Madrigal Pharmaceuticals | 6 | $168 |
| VIVUS LLC | 6 | $119 |
| Gilead Sciences, Inc. | 5 | $117 |
| QOL Medical, LLC | 4 | $110 |
| Janssen Biotech, Inc. | 2 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
Products named: IBSRELA, REZDIFFRA, CREON, PANCREAZE, Sucraid, LINZESS, TREMFYA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
